Evidence map›Paper›PMID 30917156›Full record

ArticlePloS one2019

A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis.

Matilda Rentoft, Daniel Svensson, Andreas Sjödin, Pall I Olason, Olle Sjöström, Carin Nylander, Pia Osterman, Rickard Sjögren, Sergiu Netotea, Carl Wibom and 5 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. IsmedRxiv : the preprint server for health sciences · 2024
    Article
  2. Article
  3. Massive parallel sequencing in a family with rectal cancer.Hereditary cancer in clinical practice · 2021
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Matilda RentoftDepartment of Medical Biochemistry and Biophysics, Umeå University, SE Umeå, Sweden.
Daniel SvenssonComputational Life Science Cluster, Department of Chemistry, Umeå University, SE Umeå, Sweden.ORCID 0000-0002-4476-9255
Andreas SjödinComputational Life Science Cluster, Department of Chemistry, Umeå University, SE Umeå, Sweden.
Pall I OlasonScience for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, SE Uppsala, Sweden.
Olle SjöströmDepartment of Radiation Sciences, Oncology, Umeå University, SE Umeå, Sweden.
Carin NylanderDepartment of Radiation Sciences, Oncology, Umeå University, SE Umeå, Sweden.
Pia OstermanDepartment of Medical Biochemistry and Biophysics, Umeå University, SE Umeå, Sweden.
Rickard SjögrenComputational Life Science Cluster, Department of Chemistry, Umeå University, SE Umeå, Sweden.ORCID 0000-0001-7881-0968
Sergiu NetoteaComputational Life Science Cluster, Department of Chemistry, Umeå University, SE Umeå, Sweden.
Carl WibomDepartment of Radiation Sciences, Oncology, Umeå University, SE Umeå, Sweden.
Kristina CederquistDepartment of Medical Biosciences, Medical and Clinical Genetics, Umeå University, SE Umeå, Sweden.
Andrei ChabesDepartment of Medical Biochemistry and Biophysics, Umeå University, SE Umeå, Sweden.
Johan TryggComputational Life Science Cluster, Department of Chemistry, Umeå University, SE Umeå, Sweden.
Beatrice S MelinDepartment of Radiation Sciences, Oncology, Umeå University, SE Umeå, Sweden.
Erik JohanssonDepartment of Medical Biochemistry and Biophysics, Umeå University, SE Umeå, Sweden.ORCID 0000-0002-8526-6224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. However, the vast number of genetic variants observed by this method constitutes a challenge when trying to identify the causal variants. This is often handled by restricting disease studies to the most damaging variants, e.g. those found in coding regions, and overlooking the remaining genetic variation. Such a biased approach explains in part why the genetic causes of many families with dominantly inherited diseases, in spite of being included in whole-genome sequencing studies, are left unsolved today. Here we explore the use of a geographically matched control population to minimize the number of candidate disease-causing variants without excluding variants based on assumptions on genomic position or functional predictions. To exemplify the benefit of the geographically matched control population we apply a typical disease variant filtering strategy in a family with an autosomal dominant form of colorectal cancer. With the use of the geographically matched control population we end up with 26 candidate variants genome wide. This is in contrast to the tens of thousands of candidates left when only making use of available public variant datasets. The effect of the local control population is dual, it (1) reduces the total number of candidate variants shared between affected individuals, and more importantly (2) increases the rate by which the number of candidate variants are reduced as additional affected family members are included in the filtering strategy. We demonstrate that the application of a geographically matched control population effectively limits the number of candidate disease-causing variants and may provide the means by which variants suitable for functional studies are identified genome wide.

Indexed as

Genetic VariationWhole Genome SequencingCase-Control StudiesColorectal NeoplasmsFemaleGenes, DominantGenetic Diseases, InbornGenome-Wide Association StudyGeographyHaplotypesHumansMalePedigreeSweden

Identifiers

PMID30917156
PMCPMC6436687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.